The global Platelet Function Test Market is set to experience robust growth from 2025 to 2035, with its market size projected to grow from USD 1,375.8 million in 2025 to USD 2,607.5 million by 2035 at ...

The global platelet function test market is projected to be valued at USD 1.38 billion in 2025 and is expected to reach USD 2.61 billion by 2035, registering a CAGR of 6.3% during the forecast period.

The global platelet function test market is poised for robust growth over the next decade, fueled by innovations in diagnostic technologies and increasing demand for personalized, preventive ...

Aspirin is widely prescribed for the secondary prevention of ischemic stroke and acute coronary syndromes, but some patients do not respond to this therapy. There is evidence that these ...

Against the backdrop of wide variability in thrombotic risk and clopidogrel response in patients following percutaneous coronary intervention (PCI) as well as growing use of more potent antiplatelet ...

BARCELONA, Spain—Switching from more potent antiplatelets to clopidogrel based on the results of platelet function testing shortly after PCI seems to be a viable option in patients with ACS, results ...

LOS ANGELES — Patients with intracranial aneurysm who respond poorly to the antiplatelet drug clopidogrel when treated with flow diversion using the Pipeline embolization device (Medtronic) have ...

April 10, 2009 (Munich, Germany) — A new study using platelet-aggregometry testing to assess the effects of different proton-pump inhibitors (PPIs) on platelet response to clopidogrel suggests that ...

While thrombocytopenia and bleeding are events that often occur together in neonates, this may not signify cause and effect. In fact, one study reported that 91% of neonates with low platelet counts ...